| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 1.01e-05 | 22 | 126 | 4 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 1.46e-05 | 24 | 126 | 4 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 1.73e-05 | 25 | 126 | 4 | GO:0004114 | |
| GeneOntologyMolecularFunction | cAMP binding | 1.73e-05 | 25 | 126 | 4 | GO:0030552 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 2.37e-05 | 27 | 126 | 4 | GO:0004112 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK3 IQGAP2 TBC1D5 ARHGAP35 RGL1 DENND10 ARHGEF7 PLEKHG3 SGSM2 AGAP7P AGAP4 AGAP6 | 8.92e-05 | 507 | 126 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK3 IQGAP2 TBC1D5 ARHGAP35 RGL1 DENND10 ARHGEF7 PLEKHG3 SGSM2 AGAP7P AGAP4 AGAP6 | 8.92e-05 | 507 | 126 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.05e-04 | 39 | 126 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.98e-04 | 279 | 126 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | GTPase binding | DOCK3 IQGAP2 SPTBN1 EXOC8 DENND10 ARHGEF7 PLEKHG3 SGSM2 SORL1 | 4.71e-04 | 360 | 126 | 9 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | 9.95e-04 | 321 | 126 | 8 | GO:0031267 | |
| GeneOntologyBiologicalProcess | cAMP catabolic process | 1.53e-07 | 9 | 124 | 4 | GO:0006198 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 3.49e-07 | 25 | 124 | 5 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide catabolic process | 1.19e-06 | 14 | 124 | 4 | GO:0009214 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 6.52e-06 | 44 | 124 | 5 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 7.30e-06 | 45 | 124 | 5 | GO:0009187 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | PLXNA3 IQGAP2 TBC1D5 ARHGEF7 SGSM2 AGAP7P MLST8 AGAP4 AGAP6 PLXNA2 | 3.55e-05 | 335 | 124 | 10 | GO:0043087 |
| GeneOntologyBiologicalProcess | negative regulation of relaxation of cardiac muscle | 3.59e-05 | 2 | 124 | 2 | GO:1901898 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 7.95e-06 | 46 | 125 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | cell leading edge | SPEF1 PDE4A IQGAP2 SPTBN1 SLC1A2 ITGB5 EXOC8 FAP IGF2BP1 PTPRK ARHGEF7 EXOC4 | 4.69e-05 | 500 | 125 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | calcium channel complex | 7.66e-05 | 73 | 125 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | Ndc80 complex | 2.11e-04 | 4 | 125 | 2 | GO:0031262 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.42e-04 | 155 | 125 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PDE4A PDE4B PDE4C PDE4D CALR ABCC5 RYR1 EXOC8 EPG5 IGF2BP1 SYNJ1 UBR5 EIF2AK3 DYNC1I1 SORL1 | 4.65e-04 | 934 | 125 | 15 | GO:0048471 |
| Domain | PDEase | 6.03e-06 | 19 | 121 | 4 | IPR023088 | |
| Domain | PDEase_I | 9.21e-06 | 21 | 121 | 4 | PF00233 | |
| Domain | PDEASE_I | 9.21e-06 | 21 | 121 | 4 | PS00126 | |
| Domain | PDEase_CS | 9.21e-06 | 21 | 121 | 4 | IPR023174 | |
| Domain | - | 1.12e-05 | 22 | 121 | 4 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.35e-05 | 23 | 121 | 4 | IPR002073 | |
| Domain | HD/PDEase_dom | 1.61e-05 | 24 | 121 | 4 | IPR003607 | |
| Domain | HDc | 1.61e-05 | 24 | 121 | 4 | SM00471 | |
| Domain | CH-domain | 1.26e-04 | 75 | 121 | 5 | IPR001715 | |
| Domain | PH_dom-like | LDLRAP1 SPTBN1 APBA2 EXOC8 ARHGEF7 PLEKHG3 AGAP7P AGAP4 AGAP6 ANKS1A | 4.56e-04 | 426 | 121 | 10 | IPR011993 |
| Domain | PID | 7.72e-04 | 28 | 121 | 3 | PF00640 | |
| Domain | CH | 8.37e-04 | 65 | 121 | 4 | SM00033 | |
| Domain | ArfGap | 8.57e-04 | 29 | 121 | 3 | SM00105 | |
| Domain | ARFGAP | 8.57e-04 | 29 | 121 | 3 | PS50115 | |
| Domain | ArfGap | 8.57e-04 | 29 | 121 | 3 | PF01412 | |
| Domain | ArfGAP | 8.57e-04 | 29 | 121 | 3 | IPR001164 | |
| Domain | - | LDLRAP1 SPTBN1 APBA2 EXOC8 ARHGEF7 PLEKHG3 AGAP4 AGAP6 ANKS1A | 1.01e-03 | 391 | 121 | 9 | 2.30.29.30 |
| Domain | CH | 1.11e-03 | 70 | 121 | 4 | PF00307 | |
| Domain | Calx_beta | 1.14e-03 | 8 | 121 | 2 | SM00237 | |
| Domain | PID | 1.15e-03 | 32 | 121 | 3 | PS01179 | |
| Domain | - | 1.17e-03 | 71 | 121 | 4 | 1.10.418.10 | |
| Domain | CH | 1.29e-03 | 73 | 121 | 4 | PS50021 | |
| Domain | Calx_beta | 1.45e-03 | 9 | 121 | 2 | IPR003644 | |
| Domain | Plexin_cytopl | 1.45e-03 | 9 | 121 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.45e-03 | 9 | 121 | 2 | IPR013548 | |
| Domain | Plexin | 1.45e-03 | 9 | 121 | 2 | IPR031148 | |
| Domain | Calx-beta | 1.45e-03 | 9 | 121 | 2 | PF03160 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 2.91e-07 | 23 | 90 | 5 | M46455 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.67e-06 | 16 | 90 | 4 | MM14699 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.50e-05 | 24 | 90 | 4 | M751 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 2.56e-05 | 55 | 90 | 5 | M39763 | |
| Pathway | WP_PURINE_METABOLISM | 1.10e-04 | 171 | 90 | 7 | MM15909 | |
| Pathway | REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM | 2.65e-04 | 20 | 90 | 3 | MM15208 | |
| Pathway | REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM | 3.08e-04 | 21 | 90 | 3 | M27479 | |
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 9371714 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 24732776 | ||
| Pubmed | Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice. | 1.70e-10 | 4 | 127 | 4 | 34943270 | |
| Pubmed | PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice. | 1.70e-10 | 4 | 127 | 4 | 32738081 | |
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 8413254 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 22946044 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 33609559 | ||
| Pubmed | 8.45e-10 | 5 | 127 | 4 | 33944911 | ||
| Pubmed | Interaction between LIS1 and PDE4, and its role in cytoplasmic dynein function. | 8.45e-10 | 5 | 127 | 4 | 21652625 | |
| Pubmed | 8.45e-10 | 5 | 127 | 4 | 8586960 | ||
| Pubmed | Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. | 2.53e-09 | 6 | 127 | 4 | 18923023 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 15585880 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 10213096 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24555506 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 18508768 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 17404263 | ||
| Pubmed | Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. | 4.76e-08 | 3 | 127 | 3 | 16034090 | |
| Pubmed | Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse. | 1.18e-07 | 13 | 127 | 4 | 8009369 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 21670503 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 15644445 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 11839681 | ||
| Pubmed | 3.89e-07 | 251 | 127 | 9 | 27507650 | ||
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 28383060 | ||
| Pubmed | CACNB4 PDE4A SFPQ PDE4B IMPDH2 IQGAP2 TBC1D5 SPTBN1 SLC1A2 ZNF462 UBA1 SYNJ1 UBR5 ARHGEF7 PIP4K2C ANKS1A | 4.89e-07 | 963 | 127 | 16 | 28671696 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 9.96e-07 | 281 | 127 | 9 | 28706196 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | LRRC8E SFPQ IMPDH2 CALR TBC1D5 SPTBN1 INTS8 ITGB5 EXOC8 B4GALT1 ZNF462 CCNT1 LMAN2L NDC80 PTPRK GOLIM4 EXOC4 | 1.93e-06 | 1203 | 127 | 17 | 29180619 |
| Pubmed | 2.02e-06 | 25 | 127 | 4 | 17307970 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E DOCK3 PLXNA3 FRAS1 PDE4A POLE ARHGAP35 ITGB5 C2CD2 RYR1 LMAN2L SYNJ1 SGSM2 NAV2 ULK4 SCARA3 | 2.91e-06 | 1105 | 127 | 16 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF26B TBC1D5 SPTBN1 SIK1 DNAH7 FSIP2 SYNJ1 PLEKHG3 CLK3 OTUD7A NAV2 HELZ EXOC4 ANKS1A | 3.42e-06 | 861 | 127 | 14 | 36931259 |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 3.93e-06 | 9 | 127 | 3 | 12640130 | |
| Pubmed | DOCK3 LDLRAP1 SPTBN1 APBA2 ADNP2 ABCC5 INTS8 ZNF365 SYNJ1 PTPRK SBNO1 HECTD2 SGSM2 MLST8 DYNC1I1 EXOC4 BRWD1 | 4.63e-06 | 1285 | 127 | 17 | 35914814 | |
| Pubmed | FRAS1 IMPDH2 ATR POLE TBC1D5 DHX38 EXOC8 ARHGEF7 HELZ CMTR2 EXOC4 SORL1 | 5.00e-06 | 650 | 127 | 12 | 38777146 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 5.60e-06 | 10 | 127 | 3 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 7.68e-06 | 11 | 127 | 3 | 15381706 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PLXNA3 FRAS1 ATR CALR SPC25 ITGB5 B4GALT1 IGSF10 FAP UBA1 LMAN2L PTPRK GOLIM4 SCARA3 EIF2AK3 SORL1 | 8.29e-06 | 1201 | 127 | 16 | 35696571 |
| Pubmed | TBC1D5 DHX38 HDAC8 HEATR5A SYNJ1 ARHGEF7 PIP4K2C EXOC4 ANKS1A | 1.10e-05 | 378 | 127 | 9 | 34315543 | |
| Pubmed | SFPQ KIF26B SPTBN1 ADNP2 SLC1A2 RGL1 ARHGEF7 NAV2 HELZ CPLANE1 | 1.26e-05 | 486 | 127 | 10 | 20936779 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 21047676 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 31324945 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 28235598 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23043089 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15003452 | ||
| Pubmed | PDE4D plays a critical role in the control of airway smooth muscle contraction. | 1.32e-05 | 2 | 127 | 2 | 14519662 | |
| Pubmed | Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). | 1.32e-05 | 2 | 127 | 2 | 17700644 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 17088426 | ||
| Pubmed | PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts. | 1.32e-05 | 2 | 127 | 2 | 21288894 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11267656 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 9520403 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 17727341 | ||
| Pubmed | Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4. | 1.32e-05 | 2 | 127 | 2 | 29123207 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 12921532 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11992722 | ||
| Pubmed | RNA-binding IMPs promote cell adhesion and invadopodia formation. | 1.32e-05 | 2 | 127 | 2 | 16541107 | |
| Pubmed | 1.32e-05 | 13 | 127 | 3 | 27713690 | ||
| Pubmed | 1.68e-05 | 14 | 127 | 3 | 22453919 | ||
| Pubmed | 1.68e-05 | 14 | 127 | 3 | 25852085 | ||
| Pubmed | 1.74e-05 | 87 | 127 | 5 | 33711283 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SFPQ PDE4D CALR DHX38 SPC25 B4GALT1 IGF2BP1 IGF2BP3 UBA1 NDC80 CSK UBR5 CDC16 MYBL1 EXOC4 | 2.18e-05 | 1155 | 127 | 15 | 20360068 |
| Pubmed | Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly. | 2.41e-05 | 93 | 127 | 5 | 38245532 | |
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 2.57e-05 | 16 | 127 | 3 | 29878059 | |
| Pubmed | 2.57e-05 | 16 | 127 | 3 | 28283561 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SFPQ IMPDH2 TBC1D5 DHX38 ARHGAP35 CCNT1 IGF2BP1 IGF2BP3 UBA1 SYNJ1 HELZ DHX29 ANKS1A | 3.95e-05 | 934 | 127 | 13 | 33916271 |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 20627640 | ||
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 3.96e-05 | 3 | 127 | 2 | 17296566 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 8806646 | ||
| Pubmed | SH3BP1, an exocyst-associated RhoGAP, inactivates Rac1 at the front to drive cell motility. | 3.96e-05 | 3 | 127 | 2 | 21658605 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 28356347 | ||
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 3.96e-05 | 3 | 127 | 2 | 29476152 | |
| Pubmed | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | 3.96e-05 | 3 | 127 | 2 | 16049158 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 9891060 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 3.96e-05 | 3 | 127 | 2 | 11241833 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 32134323 | ||
| Pubmed | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | 3.96e-05 | 3 | 127 | 2 | 15601260 | |
| Pubmed | Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. | 3.96e-05 | 3 | 127 | 2 | 32668274 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 11114167 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 20080952 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 25918234 | ||
| Pubmed | Expression of Fraser syndrome genes in normal and polycystic murine kidneys. | 3.96e-05 | 3 | 127 | 2 | 21993971 | |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 4.32e-05 | 53 | 127 | 4 | 15572359 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 5.79e-05 | 582 | 127 | 10 | 20467437 | |
| Pubmed | 6.18e-05 | 58 | 127 | 4 | 31067491 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PMPCB TBC1D5 ABCC5 INTS8 C2CD2 FEM1B EVA1B LMAN2L UBR5 ARHGEF7 EPHA7 | 6.94e-05 | 719 | 127 | 11 | 35337019 |
| Pubmed | 6.96e-05 | 116 | 127 | 5 | 30652415 | ||
| Pubmed | DOCK3 CACNB4 SFPQ SPTBN1 APBA2 ARHGAP35 SLC1A2 UBA1 SYNJ1 ARHGEF7 CDC16 SYN2 HELZ DHX29 | 7.51e-05 | 1139 | 127 | 14 | 36417873 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 24101214 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 27184842 | ||
| Pubmed | Architecture of the human ndc80-hec1 complex, a critical constituent of the outer kinetochore. | 7.90e-05 | 4 | 127 | 2 | 15961401 | |
| Pubmed | A genome-wide association study for age-related hearing impairment in the Saami. | 7.90e-05 | 4 | 127 | 2 | 20068591 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 23008439 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 12196561 | ||
| Pubmed | H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. | 7.90e-05 | 4 | 127 | 2 | 10875929 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 11306810 | ||
| Pubmed | Identification of two novel components of the human NDC80 kinetochore complex. | 7.90e-05 | 4 | 127 | 2 | 14699129 | |
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 7.90e-05 | 4 | 127 | 2 | 25518740 | |
| Pubmed | mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. | 7.90e-05 | 4 | 127 | 2 | 21576258 | |
| Pubmed | Semaphorin-plexin signalling genes associated with human breast tumourigenesis. | 7.90e-05 | 4 | 127 | 2 | 21925246 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 15225648 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 18268335 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 18563433 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 26160756 | ||
| GeneFamily | Phosphodiesterases | 3.90e-06 | 24 | 82 | 4 | 681 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.13e-04 | 21 | 82 | 3 | 813 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.47e-04 | 206 | 82 | 6 | 682 | |
| GeneFamily | ArfGAPs | 4.45e-04 | 33 | 82 | 3 | 395 | |
| GeneFamily | Exocyst complex | 7.17e-04 | 9 | 82 | 2 | 1055 | |
| GeneFamily | Plexins | 7.17e-04 | 9 | 82 | 2 | 683 | |
| GeneFamily | Fibronectin type III domain containing | 8.04e-04 | 160 | 82 | 5 | 555 | |
| GeneFamily | Ankyrin repeat domain containing | 8.10e-04 | 242 | 82 | 6 | 403 | |
| GeneFamily | DEAH-box helicases | 2.34e-03 | 16 | 82 | 2 | 500 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.64e-03 | 17 | 82 | 2 | 1291 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 6.15e-03 | 26 | 82 | 2 | 904 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | DOCK3 PLXNA3 CACNB4 PDE4C PDE4D CPEB3 APBA2 ABCC5 FHOD3 ARHGAP35 SLC1A2 PTPRT ZNF462 FSIP2 SYNJ1 PTPRK SYN2 BRWD1 | 5.90e-06 | 1106 | 126 | 18 | M39071 |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.99e-10 | 192 | 126 | 10 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 7.66e-07 | 178 | 126 | 7 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.32e-06 | 193 | 126 | 7 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.41e-06 | 195 | 126 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.41e-06 | 195 | 126 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.41e-06 | 195 | 126 | 7 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.46e-06 | 196 | 126 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-06 | 198 | 126 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-06 | 144 | 126 | 6 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-06 | 156 | 126 | 6 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 169 | 126 | 6 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 174 | 126 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 174 | 126 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.25e-05 | 180 | 126 | 6 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.25e-05 | 180 | 126 | 6 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 180 | 126 | 6 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.46e-05 | 185 | 126 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.46e-05 | 185 | 126 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 186 | 126 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 189 | 126 | 6 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-05 | 190 | 126 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.70e-05 | 190 | 126 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 191 | 126 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 192 | 126 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 1.85e-05 | 193 | 126 | 6 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.85e-05 | 193 | 126 | 6 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 1.85e-05 | 193 | 126 | 6 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.91e-05 | 194 | 126 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 1.91e-05 | 194 | 126 | 6 | 8a596f25f6bfa5baaa2f52d80ad92f2925713398 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 1.91e-05 | 194 | 126 | 6 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 195 | 126 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 126 | 6 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 196 | 126 | 6 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-05 | 196 | 126 | 6 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 197 | 126 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 197 | 126 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.14e-05 | 198 | 126 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.20e-05 | 199 | 126 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 199 | 126 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.20e-05 | 199 | 126 | 6 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 199 | 126 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 199 | 126 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 199 | 126 | 6 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.98e-05 | 134 | 126 | 5 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.60e-05 | 144 | 126 | 5 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 5.98e-05 | 146 | 126 | 5 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-05 | 151 | 126 | 5 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-05 | 154 | 126 | 5 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 8.19e-05 | 156 | 126 | 5 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.44e-05 | 157 | 126 | 5 | 170197b76620df31495f1247f365da382b2d8045 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.44e-05 | 157 | 126 | 5 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.44e-05 | 157 | 126 | 5 | c21520301cc0d5d4b1cc4b8ec735f9adb698e768 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.69e-05 | 158 | 126 | 5 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.78e-05 | 162 | 126 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.78e-05 | 162 | 126 | 5 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.78e-05 | 162 | 126 | 5 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-04 | 164 | 126 | 5 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | Ciliated_cells-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-04 | 165 | 126 | 5 | 0ebdbbdb151fb797335013d5838af1c7bbc45b06 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 166 | 126 | 5 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 166 | 126 | 5 | 35db3022c33d6f8bb6587d9eec89a7cccb70271a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 167 | 126 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 169 | 126 | 5 | 01a24a8817628125bd004b2be68ffa62c7111f6e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 170 | 126 | 5 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 172 | 126 | 5 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 172 | 126 | 5 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 126 | 5 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 176 | 126 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 177 | 126 | 5 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.48e-04 | 177 | 126 | 5 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-04 | 178 | 126 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 178 | 126 | 5 | ccea3c8908d72f5fecd151a133048c8e9758304c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 179 | 126 | 5 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 179 | 126 | 5 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 180 | 126 | 5 | 710526abedc8e0f9ba19ad69220df4c9468ada8f | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-04 | 180 | 126 | 5 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-04 | 180 | 126 | 5 | f3d35b2ea78afef37a84232adf5e6e26712b618d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 180 | 126 | 5 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-04 | 180 | 126 | 5 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 181 | 126 | 5 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 181 | 126 | 5 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-04 | 181 | 126 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 1.69e-04 | 182 | 126 | 5 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.69e-04 | 182 | 126 | 5 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-04 | 182 | 126 | 5 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 182 | 126 | 5 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-04 | 182 | 126 | 5 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 182 | 126 | 5 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.73e-04 | 183 | 126 | 5 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.73e-04 | 183 | 126 | 5 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.73e-04 | 183 | 126 | 5 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | RA-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.73e-04 | 183 | 126 | 5 | 6397f684a50346fc42cccb5afbe10350f4b2d9b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 183 | 126 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 184 | 126 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 184 | 126 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 184 | 126 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | (3)_Mast_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.77e-04 | 184 | 126 | 5 | dbfad62b925d835632b39a88ab95bd9af9cb7bee | |
| ToppCell | (3)_Mast_cell|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.77e-04 | 184 | 126 | 5 | 482907d3669597e25c8ff3e9a802a31415a0d654 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-04 | 185 | 126 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 185 | 126 | 5 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| Drug | Piclamilast | 8.66e-10 | 4 | 125 | 4 | DB01791 | |
| Drug | Ibudilast | 4.31e-09 | 5 | 125 | 4 | DB05266 | |
| Drug | 1,7-naphthyridine | 4.31e-09 | 5 | 125 | 4 | CID000009209 | |
| Drug | Ketotifen | 2.99e-08 | 7 | 125 | 4 | DB00920 | |
| Drug | Iloprost | 2.99e-08 | 7 | 125 | 4 | DB01088 | |
| Drug | Dyphylline | 5.96e-08 | 8 | 125 | 4 | DB00651 | |
| Drug | trequinsin | 1.07e-07 | 9 | 125 | 4 | ctd:C035964 | |
| Drug | L-826,141 | 1.07e-07 | 9 | 125 | 4 | ctd:C459562 | |
| Drug | 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid | 1.62e-07 | 3 | 125 | 3 | DB08299 | |
| Drug | NVP ABE171 | 1.77e-07 | 10 | 125 | 4 | ctd:C451724 | |
| Drug | zaprinast | 1.13e-06 | 141 | 125 | 8 | CID000005722 | |
| Drug | Roflumilast | 1.50e-06 | 16 | 125 | 4 | ctd:C424423 | |
| Drug | D-22888 | 1.60e-06 | 5 | 125 | 3 | CID000197714 | |
| Drug | Cilomilast | 2.50e-06 | 18 | 125 | 4 | ctd:C433247 | |
| Drug | AA-2379 | 4.82e-06 | 21 | 125 | 4 | CID000128390 | |
| Drug | HWA 153 | 5.87e-06 | 22 | 125 | 4 | CID000162797 | |
| Drug | griseolic acid | 7.07e-06 | 23 | 125 | 4 | CID000127607 | |
| Drug | atherosperminine | 7.07e-06 | 23 | 125 | 4 | CID000096918 | |
| Drug | KF18280 | 8.87e-06 | 8 | 125 | 3 | CID003071941 | |
| Drug | desethyl KBT-3022 | 1.18e-05 | 26 | 125 | 4 | CID000127736 | |
| Drug | T-440 | 1.18e-05 | 26 | 125 | 4 | CID000177965 | |
| Drug | Ro 15-2041 | 1.18e-05 | 26 | 125 | 4 | CID000132434 | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 5631_UP | |
| Drug | imidazole-4-carboxamide | 2.76e-05 | 32 | 125 | 4 | CID000152917 | |
| Drug | V11294 Analogue 5f | 2.99e-05 | 2 | 125 | 2 | CID011214587 | |
| Drug | V11294 Analogue 5t | 2.99e-05 | 2 | 125 | 2 | CID011226695 | |
| Drug | V11294 Analogue 5e | 2.99e-05 | 2 | 125 | 2 | CID011443441 | |
| Drug | V11294 Analogue 5n | 2.99e-05 | 2 | 125 | 2 | CID011238279 | |
| Drug | V11294 Analogue 5p | 2.99e-05 | 2 | 125 | 2 | CID011478659 | |
| Drug | V11294 Analogue 5o | 2.99e-05 | 2 | 125 | 2 | CID011249748 | |
| Drug | V11294 Analogue 5c | 2.99e-05 | 2 | 125 | 2 | CID011179896 | |
| Drug | V11294 Analogue 5b | 2.99e-05 | 2 | 125 | 2 | CID011443760 | |
| Drug | Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid | 2.99e-05 | 2 | 125 | 2 | DB03849 | |
| Drug | T-2585.HCl | 2.99e-05 | 2 | 125 | 2 | CID006918355 | |
| Drug | V11294 Analogue 5m | 2.99e-05 | 2 | 125 | 2 | CID011477773 | |
| Drug | V11294 Analogue 8a | 2.99e-05 | 2 | 125 | 2 | CID011442865 | |
| Drug | V11294 Analogue 5q | 2.99e-05 | 2 | 125 | 2 | CID011318772 | |
| Drug | V11294 Analogue 5h | 2.99e-05 | 2 | 125 | 2 | CID011306698 | |
| Drug | 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | 2.99e-05 | 2 | 125 | 2 | DB01959 | |
| Drug | 4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone | 2.99e-05 | 2 | 125 | 2 | DB01954 | |
| Drug | M 98 | 2.99e-05 | 2 | 125 | 2 | CID006420180 | |
| Drug | V11294 Analogue 5i | 2.99e-05 | 2 | 125 | 2 | CID011376249 | |
| Drug | V11294 Analogue 5d | 2.99e-05 | 2 | 125 | 2 | CID011283750 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzoic acid | 2.99e-05 | 2 | 125 | 2 | CID002779323 | |
| Drug | V11294 Analogue 5v | 2.99e-05 | 2 | 125 | 2 | CID011375325 | |
| Drug | 3-cyclopentyloxy-4-methoxybenzaldehyde | 2.99e-05 | 2 | 125 | 2 | CID002735893 | |
| Drug | Np-V | 2.99e-05 | 2 | 125 | 2 | CID009999276 | |
| Drug | (S)-Rolipram | 2.99e-05 | 2 | 125 | 2 | DB03606 | |
| Drug | 1-((5-(1-aminoethyl)-2-(8-methoxy-2-(triflurormethyl)-5-quinolinyl)-4-oxazolyl) carbonyl)-4-((cyclopropylcarbonyl)amino)proline ethyl ester | 2.99e-05 | 2 | 125 | 2 | ctd:C554440 | |
| Drug | V11294 Analogue 5r | 2.99e-05 | 2 | 125 | 2 | CID011168555 | |
| Drug | V11294 Analogue 5j | 2.99e-05 | 2 | 125 | 2 | CID011433797 | |
| Drug | V11294 Analogue 5a | 2.99e-05 | 2 | 125 | 2 | CID011386897 | |
| Drug | V11294 Analogue 5k | 2.99e-05 | 2 | 125 | 2 | CID011456440 | |
| Drug | (R)-Rolipram | 2.99e-05 | 2 | 125 | 2 | DB04149 | |
| Drug | (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one | 2.99e-05 | 2 | 125 | 2 | DB06842 | |
| Drug | dyphylline | 3.13e-05 | 33 | 125 | 4 | CID000003182 | |
| Drug | felodipine | 4.19e-05 | 169 | 125 | 7 | CID000003333 | |
| Drug | PDEs | 4.40e-05 | 116 | 125 | 6 | CID003036959 | |
| Drug | AH 21-132 | 4.97e-05 | 37 | 125 | 4 | CID003035793 | |
| Drug | papaverine | 5.42e-05 | 176 | 125 | 7 | CID000004680 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 6.25e-05 | 180 | 125 | 7 | 4541_DN | |
| Drug | NSC18930 | 6.63e-05 | 77 | 125 | 5 | CID000001189 | |
| Drug | DTIC | 8.45e-05 | 81 | 125 | 5 | CID005281007 | |
| Drug | CDP840 | 8.59e-05 | 16 | 125 | 3 | CID000127928 | |
| Drug | Isotretinoin [4759-48-2]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 8.78e-05 | 190 | 125 | 7 | 6017_UP | |
| Drug | BW A78U | 8.94e-05 | 3 | 125 | 2 | CID000127779 | |
| Drug | Enprofylline | 8.94e-05 | 3 | 125 | 2 | DB00824 | |
| Drug | Org 4428 | 8.94e-05 | 3 | 125 | 2 | CID000166560 | |
| Drug | 1-Pyrrolidinebutanenitrile | 8.94e-05 | 3 | 125 | 2 | CID000118838 | |
| Drug | AC1L73CW | 1.00e-04 | 84 | 125 | 5 | CID000328776 | |
| Drug | Org 9935 | 1.04e-04 | 17 | 125 | 3 | CID000131100 | |
| Drug | Caffeine | 1.78e-04 | 4 | 125 | 2 | DB00201 | |
| Drug | milrinone | 1.82e-04 | 150 | 125 | 6 | CID000004197 | |
| Drug | sildenafil | 1.89e-04 | 96 | 125 | 5 | CID000005212 | |
| Drug | siguazodan | 2.31e-04 | 22 | 125 | 3 | CID000072124 | |
| Drug | guanine derivative | 2.64e-04 | 23 | 125 | 3 | CID000129161 | |
| Disease | neuroimaging measurement | KIF26B TBC1D5 FAT3 SPTBN1 SPC25 ARHGAP35 ITGB5 ZNF462 IGF2BP1 SYNJ1 CSK SBNO1 NAV2 EIF2AK3 PLXNA2 EXOC4 ANKS1A | 2.26e-06 | 1069 | 123 | 17 | EFO_0004346 |
| Disease | cerebral palsy (implicated_via_orthology) | 8.30e-06 | 10 | 123 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma | 2.85e-05 | 42 | 123 | 4 | EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354 | |
| Disease | Benign neoplasm of stomach | 4.61e-05 | 17 | 123 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.61e-05 | 17 | 123 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 4.61e-05 | 17 | 123 | 3 | C0154060 | |
| Disease | Early myoclonic encephalopathy | 5.16e-05 | 3 | 123 | 2 | cv:C0270855 | |
| Disease | Stomach Carcinoma | 8.90e-05 | 21 | 123 | 3 | C0699791 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 1.03e-04 | 4 | 123 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | KIF26B TBC1D5 FAT3 SPTBN1 SPC25 ZNF462 SBNO1 NAV2 EXOC4 ANKS1A | 1.07e-04 | 550 | 123 | 10 | EFO_0004346, EFO_0004464 |
| Disease | late-onset Alzheimers disease | 2.31e-04 | 292 | 123 | 7 | EFO_1001870 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 2.56e-04 | 6 | 123 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Schizophrenia | PDE4A PDE4B PDE4D APBA2 ADNP2 SLC1A2 LMAN2L SBNO1 SYN2 ULK4 PIP4K2C PLXNA2 | 3.30e-04 | 883 | 123 | 12 | C0036341 |
| Disease | retinal detachment, retinal break | 4.20e-04 | 35 | 123 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | lifestyle measurement | 4.68e-04 | 235 | 123 | 6 | EFO_0010724 | |
| Disease | endometrial cancer (implicated_via_orthology) | 4.75e-04 | 8 | 123 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | age at initiation of corrective lens use | 4.75e-04 | 8 | 123 | 2 | EFO_0021781 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 5.79e-04 | 39 | 123 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | smoking behavior | 5.85e-04 | 341 | 123 | 7 | EFO_0004318 | |
| Disease | venous thromboembolism | 7.09e-04 | 460 | 123 | 8 | EFO_0004286 | |
| Disease | Adenocarcinoma of large intestine | 7.10e-04 | 96 | 123 | 4 | C1319315 | |
| Disease | cortical thickness | TBC1D5 FAT3 SPTBN1 ARHGAP35 ITGB5 ZNF462 IGF2BP1 CSK NAV2 PLXNA2 EXOC4 EPHA7 ANKS1A | 7.74e-04 | 1113 | 123 | 13 | EFO_0004840 |
| Disease | hepatocyte growth factor measurement | 8.26e-04 | 44 | 123 | 3 | EFO_0006903 | |
| Disease | metachronous colorectal adenoma | 8.83e-04 | 45 | 123 | 3 | EFO_0803377 | |
| Disease | anxiety disorder, stress-related disorder | 1.11e-03 | 12 | 123 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | Metastatic melanoma | 1.50e-03 | 54 | 123 | 3 | C0278883 | |
| Disease | fertility measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0006923 | |
| Disease | immature platelet measurement | 1.58e-03 | 119 | 123 | 4 | EFO_0803541 | |
| Disease | infant head circumference | 1.75e-03 | 15 | 123 | 2 | EFO_0004577 | |
| Disease | N-acetylmethionine measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0021427 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.75e-03 | 206 | 123 | 5 | C0152013 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.94e-03 | 59 | 123 | 3 | EFO_0009658, GO_0009410 | |
| Disease | cup-to-disc ratio measurement | 2.22e-03 | 430 | 123 | 7 | EFO_0006939 | |
| Disease | response to phenylephrine | 2.25e-03 | 17 | 123 | 2 | EFO_0010152 | |
| Disease | spinal stenosis | 2.25e-03 | 17 | 123 | 2 | EFO_0007490 | |
| Disease | osteoarthritis | 2.43e-03 | 222 | 123 | 5 | MONDO_0005178 | |
| Disease | Malignant neoplasm of endometrium | 2.52e-03 | 18 | 123 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 2.52e-03 | 18 | 123 | 2 | C0346191 | |
| Disease | hearing loss | 2.79e-03 | 67 | 123 | 3 | EFO_0004238 | |
| Disease | creatinine measurement | IMPDH2 ZNF607 KIF26B INTS8 RYR1 B4GALT1 FAP IGF2BP3 SYN2 SORL1 TDRD12 | 3.02e-03 | 995 | 123 | 11 | EFO_0004518 |
| Disease | number of teeth measurement | 3.12e-03 | 20 | 123 | 2 | EFO_0010073 | |
| Disease | Endometrial Carcinoma | 3.42e-03 | 72 | 123 | 3 | C0476089 | |
| Disease | haptoglobin measurement | 3.44e-03 | 21 | 123 | 2 | EFO_0004640 | |
| Disease | eosinophil count | DOCK3 ATR TBC1D5 SPTBN1 SPC25 ABCC5 DNAH7 FAP IGF2BP1 SRGN CD33 CDC16 SYN2 VWA3B | 3.68e-03 | 1488 | 123 | 14 | EFO_0004842 |
| Disease | lung cancer (is_implicated_in) | 3.69e-03 | 74 | 123 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Dermatologic disorders | 3.84e-03 | 75 | 123 | 3 | C0037274 | |
| Disease | Bipolar Disorder | 3.93e-03 | 477 | 123 | 7 | C0005586 | |
| Disease | sensory peripheral neuropathy, remission | 4.12e-03 | 23 | 123 | 2 | EFO_0009785, MONDO_0002321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVMARDAHGNTALTY | 626 | Q96P64 | |
| NVESYLEEFDSMAHQ | 271 | Q9HCE0 | |
| TENFLYHLAAAEQML | 341 | Q6NSW5 | |
| FSDVDLIPMNDHNAY | 246 | P15291 | |
| EYSSEHQAADMAEID | 481 | Q9Y6R9 | |
| EIHGRDDYSFNNTMA | 786 | Q5SY80 | |
| MDHEDISESVDAAYN | 746 | Q9NZJ5 | |
| RDSAQMAYLTHFEED | 421 | Q6PIY5 | |
| ALHYAIDNENISMAR | 141 | A6NC57 | |
| SYMLQDSLEHVQLFD | 581 | P49761 | |
| ANTLNPYHEANDDLM | 171 | Q8IYT2 | |
| FENLMQLVEHYTSDA | 146 | P41240 | |
| EMYNDDLIHFSNSEN | 551 | Q99767 | |
| DYHTDRQDIQKSMAA | 426 | Q14155 | |
| SNYQTEMGSALHEAA | 241 | Q92625 | |
| DYQDTVNMLHSLLSA | 656 | O60563 | |
| SALAMADSDHLTIYN | 1126 | Q7Z478 | |
| DHSSLGLEQLQDYMV | 406 | Q9NUG4 | |
| ASALMDLVQGVYHEN | 216 | Q86YH6 | |
| ERRSLMTSDENYHNE | 451 | O00305 | |
| NANASSQDALMYHIL | 221 | Q6IQ32 | |
| DVMARDAHGNTALTY | 626 | Q5VW22 | |
| NDGRILALDMEHYSN | 861 | Q06278 | |
| LLNTTMDHLNEYAGE | 596 | P98198 | |
| LMFEELSDIFSDHNN | 356 | Q9NZL6 | |
| LQEQNSHDAMDSYYD | 916 | Q75QN2 | |
| VLDTGLTAQDMHYAQ | 271 | Q5SW96 | |
| LEIENMGAHLNAYTS | 121 | O75439 | |
| YFSVSDMDHNHLDNQ | 1806 | Q86XX4 | |
| NMENHNSALAAEASE | 221 | Q96LI6 | |
| YENDVAAMSLQSHLI | 351 | Q9NZI8 | |
| TVEMDEELHYASLNF | 331 | P20138 | |
| SLDAMDKHLSSQNRY | 416 | P12268 | |
| MVLTLEQAAGSEHYD | 201 | Q2KJY2 | |
| DLDMHALQRSTQYDG | 666 | Q5U5R9 | |
| ELMVASYNNNEDAPH | 301 | O14576 | |
| KNISDADVHNAMDNY | 426 | Q9UK73 | |
| IYDMLLSSENAHQRS | 1361 | Q5CZC0 | |
| AHIDPDASYMAAVNS | 176 | Q9BVC4 | |
| DQDMNAYLAEQSRLH | 1826 | O75051 | |
| MDAYLVEQSRLHASD | 1806 | P51805 | |
| ELALMYNDESVLENH | 491 | P27815 | |
| ALMYNDESVLENHHL | 466 | Q07343 | |
| ELALMYNDASVLENH | 446 | Q08493 | |
| LALMYNDSSVLENHH | 521 | Q08499 | |
| SAMVNNGSLSYDHER | 176 | Q9H0V9 | |
| NDFAFMLHLIDQYDS | 361 | Q6NSJ5 | |
| SFHYLMDSEAQEDTR | 31 | A6NDL7 | |
| MYQEHINEINAELSA | 1406 | Q07864 | |
| LAYDQAHFSALVSME | 361 | Q8TE49 | |
| EDNYVTVMDLLAHAN | 396 | Q15375 | |
| NGDLVEYDADHMAQL | 186 | Q8IYI6 | |
| IDAASTEDLEYLMHA | 381 | P42694 | |
| HLNEANEYTASNQMD | 301 | P18084 | |
| YENDIASMNLQAHLI | 351 | O00425 | |
| YSSMLNAKHLAEASQ | 211 | A6NG13 | |
| EMSSDLHSLATFIYN | 521 | Q9UMZ3 | |
| GESSNYINAALMDSH | 1226 | O14522 | |
| AHYDAMDNDIVQGAE | 481 | O00461 | |
| THEELMNLNGDYATI | 766 | O15440 | |
| LNLMHDLSAYSDQFL | 591 | Q96A65 | |
| VESEHDQAMAAYFTA | 346 | Q13042 | |
| DALIYMQVNSSFEDH | 571 | Q13535 | |
| RDMELLSNSLAAYAH | 6 | Q9NVM1 | |
| LELQMADSFDTGVYH | 536 | Q6WRI0 | |
| EALSHLYNESASTME | 1376 | Q86XA9 | |
| TSLSQDHDAALMQGY | 521 | Q9Y426 | |
| DHDAALMQGYTASVD | 526 | Q9Y426 | |
| DEMLSLSLHYSNALQ | 196 | Q9BXL6 | |
| DMHLQAENYTEAAFT | 1246 | Q8IZD9 | |
| YDTFNLHSLENSLMD | 341 | Q8NE35 | |
| DNIMALNNAFLDDSH | 401 | Q8NE35 | |
| SSSLNDEYGMHLENQ | 1631 | Q9H799 | |
| DEYGMHLENQKLSSS | 1636 | Q9H799 | |
| SIYDDMKNHRESNSN | 521 | P43004 | |
| LAASSYIRDHLNAMN | 261 | Q8WXX0 | |
| SIDADSENNKMVHYQ | 2311 | Q8TDW7 | |
| LSYAEDAAEHENMKA | 1301 | Q2V2M9 | |
| SLDQTDMHGDSEYNI | 116 | P27797 | |
| HYVAELNMDDLQSSA | 186 | Q8N5I4 | |
| DVMARDAHGNTALTY | 626 | Q5VUJ5 | |
| GHSAEISDMAVNYEN | 226 | Q9NSI6 | |
| EMATFHTDAYLQHLQ | 66 | Q9BY41 | |
| TENFLYHLAAAEQML | 341 | Q8TCE6 | |
| LDNISSFLDDHEENM | 311 | Q6AZY7 | |
| DALMHWLDQYNSSAD | 1261 | A3KN83 | |
| FETHTLEEHNLANYM | 4976 | P21817 | |
| TNGYDQYDDLNMHLE | 131 | A0A1B0GVH4 | |
| DTDNYTHDVFMNDSL | 116 | Q8WW35 | |
| LNSLDEHTSEFYSMD | 311 | P10243 | |
| MDRSYADQSTLHAED | 801 | Q15262 | |
| SEDIADMHSNLSNYH | 156 | Q8TBX8 | |
| QAGDLEHMETRNYSA | 26 | Q8NGV5 | |
| FDMANNVILYHDTDA | 146 | Q6ZN16 | |
| NTYSDNIIFRMEDGH | 511 | P0C091 | |
| LNLVAHADGTYAVDM | 151 | Q92777 | |
| NMDGSAAYHLVSEDV | 906 | Q92673 | |
| ASEHAADIQMVNFDY | 321 | O43426 | |
| LSLFDYEQLMAQEHS | 986 | A1L390 | |
| LDHDVDYQKLNSAMN | 26 | Q587J7 | |
| GENEHLSSMNNYLSE | 1156 | Q13576 | |
| MEFIENLDALHSYLA | 16 | O75343 | |
| MLRTHSLSNADGQYD | 1586 | Q8IVL1 | |
| LDSELFELMHQNGDY | 891 | O43147 | |
| MFDYLTSNGHLSENE | 111 | A0A0B4J2F2 | |
| MFDYLTSNGHLSENE | 111 | P57059 | |
| NIIEATHMYDNAAEA | 946 | Q9NRY4 | |
| SQENAAYLPDMAEHD | 191 | Q8IYS1 | |
| MFSLHLNEARDYEVS | 171 | Q9HBM1 | |
| LTAQDMSYDEARNLH | 1296 | Q01082 | |
| FDFELTQHDMDNILS | 281 | Q96JD6 | |
| NMNTADAAFYPDHAL | 271 | Q8IV77 | |
| SEMEDAYHEHQANLL | 521 | P23246 | |
| DDNLEHYKNSTVMAR | 671 | Q12884 | |
| DPDLMAYLSSLHQDN | 311 | O15156 | |
| VQTYTAMDLHADSLD | 126 | Q70YC5 | |
| DAQQDYHLEYAMENS | 101 | Q6UVY6 | |
| MASSVDEEALHQLYL | 1 | Q9Y4P9 | |
| DYSDDDTQEHKAQAM | 131 | A6NLU5 | |
| MEQDYQLVDESDAFH | 116 | P10124 | |
| MENYDNLVSLAGHSV | 36 | Q96SK3 | |
| YSAIIMDEAHERSLN | 646 | Q92620 | |
| HLDYVMAAANLFAQT | 761 | P22314 | |
| YALSNTAMELEFQAH | 176 | Q401N2 | |
| EAMNVLNFDHSDLIY | 911 | Q96JM2 | |
| LEHDAYAVFSQLMET | 246 | Q92609 | |
| QGHSDLEKMQDLYSE | 686 | Q502W6 | |
| YAESLSEAMEKSAHQ | 256 | Q6BDS2 | |
| DFLNYALSLMRSHND | 1916 | O95071 | |
| DSNMELLYEQGLVSH | 1066 | Q96C45 | |
| VEDVLAAASYLHMND | 146 | Q9H5J0 | |
| QAYMSNLESHSAILD | 311 | O14777 |